![PDF) Achievement of Remission Endpoints with Secukinumab Over 3 Years in Active Ankylosing Spondylitis: Pooled Analysis of Two Phase 3 Studies PDF) Achievement of Remission Endpoints with Secukinumab Over 3 Years in Active Ankylosing Spondylitis: Pooled Analysis of Two Phase 3 Studies](https://i1.rgstatic.net/publication/347847316_Achievement_of_Remission_Endpoints_with_Secukinumab_Over_3_Years_in_Active_Ankylosing_Spondylitis_Pooled_Analysis_of_Two_Phase_3_Studies/links/5ff95e4da6fdccdcb83ef0ac/largepreview.png)
PDF) Achievement of Remission Endpoints with Secukinumab Over 3 Years in Active Ankylosing Spondylitis: Pooled Analysis of Two Phase 3 Studies
![PDF) The tumorigenic diversity of the three PLAG family members is associated with different DNA binding capacities PDF) The tumorigenic diversity of the three PLAG family members is associated with different DNA binding capacities](https://i1.rgstatic.net/publication/11474226_The_tumorigenic_diversity_of_the_three_PLAG_family_members_is_associated_with_different_DNA_binding_capacities/links/0fcfd50fff1977dec4000000/largepreview.png)
PDF) The tumorigenic diversity of the three PLAG family members is associated with different DNA binding capacities
Zoë Van Acker - Postdoctoral Fellow Research Foundation – Flanders (FWO) - Laboratory of Membrane Trafficking; VIB-KU Leuven Center for Brain & Disease Research | LinkedIn
![The Quorum Sensing Inhibitor Hamamelitannin Increases Antibiotic Susceptibility of Staphylococcus aureus Biofilms by Affecting Peptidoglycan Biosynthesis and eDNA Release | Scientific Reports The Quorum Sensing Inhibitor Hamamelitannin Increases Antibiotic Susceptibility of Staphylococcus aureus Biofilms by Affecting Peptidoglycan Biosynthesis and eDNA Release | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fsrep20321/MediaObjects/41598_2016_Article_BFsrep20321_Fig3_HTML.jpg)